FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileNRx Pharmaceuticals, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NRXP
NRx Pharmaceuticals, Inc. Stock AnalysisComprehensive stock analysis for NRx Pharmaceuticals, Inc. (NRXP) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNRXP
NRXP
NRx Pharmaceuticals, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NRXP
  1. Home
  2. Stocks
  3. NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc.

🇺🇸NRXP•NASDAQ

NRx Pharmaceuticals, Inc.

🇺🇸NRXP•NASDAQ
Market cap
$124.12M

Your view on NRXP

Mkt Cap
$124.12M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About NRx Pharmaceuticals, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Jonathan C. Javitt
Headquarters
US
Industry
Biotechnology
Sector
Healthcare
CEO
Jonathan C. Javitt
Headquarters
US
Description

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior.

The company was founded in 2015 and is based in Wilmington, Delaware.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for NRx Pharmaceuticals, Inc.. Starting points for NRx Pharmaceuticals, Inc.: EPS -$0.46, beta 2.07 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for NRx Pharmaceuticals, Inc.. Trailing twelve-month EPS for NRx Pharmaceuticals, Inc. stands at -$0.46. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for NRx Pharmaceuticals, Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold NRXP12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
VTVTvTv Therapeutics Inc.HealthcareNASDAQ$64.2M
VXL.VVaxil Bio Ltd.HealthcareTSXV$410,937
VXRTVaxart, Inc.HealthcareOTC$129.3M
VYGRVoyager Therapeutics, Inc.HealthcareNASDAQ$103.9M
WHWKWhitehawk Therapeutics IncHealthcareNASDAQ$184.7M
WINTWindtree Therapeutics, Inc.HealthcareNASDAQ$1.8M
WSNAFWesana Health Holdings Inc.HealthcareOTC$341,000
WVEWave Life Sciences Ltd.HealthcareNASDAQ$546.3M
WXIBFWuXi Biologics (Cayman) Inc.HealthcareOTC$21.3B
WXXWYWuXi Biologics (Cayman) Inc.HealthcareOTC$21.7B
XAGELongevity Health Holdings Inc.HealthcareOTC$415,447
XBIOXenetic Biosciences, Inc.HealthcareNASDAQ$3.6M
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold NRx Pharmaceuticals, Inc., and how their positions are changing. At a $124.1M market value, institutional positions materially move NRx Pharmaceuticals, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by NRx Pharmaceuticals, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for NRx Pharmaceuticals, Inc.. Coverage tracks NRx Pharmaceuticals, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of NRx Pharmaceuticals, Inc.

NRXP AnalysisWeak
Past
4
Growth
2
Health
1
Profit
1
Value
1

News

Latest Market News